APA (7th ed.) Citation

Dubé, E., Bonnefoy, A., Merlen, C., Rivard, G., St‐Louis, J., Castilloux, J., . . . Warner, M. (2018). A prospective surveillance study of inhibitor development in haemophilia A patients following a population switch to a third‐generation B‐domain‐deleted recombinant factor VIII. Haemophilia, 24(2), 236. https://doi.org/10.1111/hae.13410

Chicago Style (17th ed.) Citation

Dubé, E., et al. "A Prospective Surveillance Study of Inhibitor Development in Haemophilia A Patients Following a Population Switch to a Third‐generation B‐domain‐deleted Recombinant Factor VIII." Haemophilia 24, no. 2 (2018): 236. https://doi.org/10.1111/hae.13410.

MLA (9th ed.) Citation

Dubé, E., et al. "A Prospective Surveillance Study of Inhibitor Development in Haemophilia A Patients Following a Population Switch to a Third‐generation B‐domain‐deleted Recombinant Factor VIII." Haemophilia, vol. 24, no. 2, 2018, p. 236, https://doi.org/10.1111/hae.13410.